Local Institution - 0315

Koto, Tokyo 135-8550

0 studies enrolling now · 1 studies all time

What they study most

Extensive-Stage Small Cell Lung Cancer

Studies at this site

• A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS). — Recruiting now